In this report we will share some good news. As a result of the current government stimulus bill, there are extensions of important tax credits and tax reductions to reward energy conservation. There are likewise some substantial increases in the advantages for property owner. We are positive that the information offered in this report can benefit millions of individuals and […]
Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) and Impax Laboratories Inc (NASDAQ: IPXL) were up on Wednesday, after analysts at Deutsche Bank initiated coverage on Tuesday.
Sagent Pharmaceuticals
The analysts initiated coverage of Sagent with a Buy rating and a $29 price target. They say they have always liked the biotech company’s “focus on the attractive generic injectables segment but now believe […]
Momentum Stocks: Caution Ahead (Part 4 of 6)(Continued from Part 3)Another case in point is biotech.Biotech is another obvious example of the momentum trade. It is a high “beta” or risky industry that has been a strong relative performer for many years. Through the close of the week ended March 20, the Nasdaq Biotech Index had surged 20% year-to-date. The following […]
SAN FRANCISCO (MarketWatch)—Investors looking for early warnings signs of a shift in U.S. market sentiment would do well to watch tech and biotech stocks.That is because a selloff in those sectors is likely to signal that investors’ confidence in U.S. equities is deteriorating, according to Bank of America Merrill Lynch analyst Michael Hartnett“U.S. bear view requires [a] tech-wreck,” he writes […]
Biotech bubble may just be an optical illusion
By iCELL News on March 27, 2015 · Sector
SAN FRANCISCO (MarketWatch)—The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse.“There are optics suggesting that […]
Wikimedia CommonsThere is probably a bubble in biotech stocks. In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what it […]
View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks.
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]
Akin Oyedele
Mar. 27, 2015, 8:54 AM
542
Wikimedia CommonsCredit Suisse analysts say biotechs are not in a bubble.Still, in a note Friday, the firm presents evidence for the industry being in in a bubble, and other evidence that it definitely isn’t.The signs that there’s a bubble, they wrote, are that the NYSE Biotech Index has gained 204% versus 64% for the S&P 500 since […]
View photo.By and large, the short interest moves in the leading biotechs and emerging pharmaceuticals were mild between the February 27 and March 13 settlement dates. However, Celgene Corporation (NASDAQ: CELG), Illumina, Inc. (NASDAQ: ILMN) and Medivation Inc (NASDAQ: MDVN) saw double-digit percentage upswings in their short interest.Here we take a quick look at how these three stocks have fared […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
